Radial distribution of stars, gas and dust in SINGS galaxies. III. Modeling the evolution of the stellar component in galaxy disks

(Abridged) We analyze the evolution of 42 spiral galaxies in the Spitzer Infrared Nearby Galaxies Survey, using extinction-corrected UV, optical and near-infrared radial profiles to probe the emission of stars of different ages as a function of radius. We fit these profiles with models that describe the chemical and spectro-photometric evolution of spiral disks within a self-consistent framework. These backward models succesfully reproduce the multi-wavelength profiles of our galaxies, except the UV profiles of some early-type disks. From the model fitting we infer the maximum circular velocity of the rotation curve (Vc) and the dimensionless spin parameter (lambda). The values of Vc are in good agreement with the velocities measured in HI rotation curves. While our sample is not volume-limited, the resulting distribution of spins is close to the lognormal function obtained in cosmological N-body simulations, peaking at ~0.03 regardless of the total halo mass. We do not find any evident trend between spin and Hubble type, besides an increase in the scatter for the latest types. According to the model, galaxies evolve along a roughly constant mass-size relation, increasing their scale-lengths as they become more massive. The radial scale-length of most disks in our sample seems to have increased at a rate of 0.05-0.06 kpc/Gyr, being now 20-25% larger than at z=1.Comment: Accepted for publication in ApJ. 32 pages in emulateapj format, 25 figures. The whole figureset of Fig. 2 can be downloaded from http://www.cv.nrao.edu/~jmunoz/f2_all.p

Ultraviolet through far-infrared spatially resolved analysis of the recent star formation in M81 (NGC 3031)

The recent star formation (SF) in the early-type spiral galaxy M81 is characterized using imaging observations from the far-ultraviolet to the far-infrared. We compare these data with models of the stellar, gas, and dust emission for subgalactic regions. Our results suggest the existence of a diffuse dust emission not directly linked to the recent star formation. We find a radial decrease of the dust temperature and dust mass density, and in the attenuation of the stellar light. The IR emission in M81 can be modeled with three components: (1) cold dust with a temperature = 18 ± 2 K, concentrated near the H II regions but also presenting a diffuse distribution; (2) warm dust with = 53 ± 7 K, directly linked with the H II regions; and (3) aromatic molecules, with diffuse morphology peaking around the H II regions. We derive several relationships to obtain total IR luminosities from IR monochromatic fluxes, and we compare five different star formation rate (SFR) estimators for H II regions in M81 and M51: the UV, H alpha, and three estimators based on Spitzer data. We find that the H alpha luminosity absorbed by dust correlates tightly with the 24 mu m emission. The correlation with the total IR luminosity is not as good. Important variations from galaxy to galaxy are found when estimating the total SFR with the 24 mu m or the total IR emission alone. The most reliable estimations of the total SFRs are obtained by combining the H alpha emission (or the UV) and an IR luminosity (especially the 24 mu m emission), which probe the unobscured and obscured SF, respectively. For the entire M81 galaxy, about 50% of the total SF is obscured by dust. The percentage of obscured SF ranges from 60% in the inner regions of the galaxy to 30% in the outer zones

Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer

Bone is one of the most frequent sites for metastasis in breast cancer patients often resulting in significant clinical morbidity and mortality. Bisphosphonates are currently the standard of care for breast cancer patients with bone metastasis. We have shown previously that doxycycline, a member of the tetracycline family of antibiotics, reduces total tumour burden in an experimental bone metastasis mouse model of human breast cancer. In this study, we combined doxycycline treatment together with zoledronic acid, the most potent bisphosphonate. Drug administration started 3 days before the injection of the MDA-MB-231 cells. When mice were administered zoledronic acid alone, the total tumour burden decreased by 43% compared to placebo treatment. Administration of a combination of zoledronic acid and doxycycline resulted in a 74% decrease in total tumour burden compared to untreated mice. In doxycycline- and zoledronate-treated mice bone formation was significantly enhanced as determined by increased numbers of osteoblasts, osteoid surface and volume, whereas a decrease in bone resorption was also observed. Doxycycline greatly reduced tumour burden and could also compensate for the increased bone resorption. The addition of zoledronate to the regimen further decreased tumour burden, caused an extensive decrease in bone-associated soft tissue tumour burden (93%), and sustained the bone volume, which could result in a smaller fracture risk. Treatment with zoledronic acid in combination with doxycycline may be very beneficial for breast cancer patients at risk for osteolytic bone metastasis

Decision Process in Human-Agent Interaction: Extending Jason Reasoning Cycle

The main characteristic of an agent is acting on behalf of humans. Then, agents are employed as modeling paradigms for complex systems and their implementation. Today we are witnessing a growing increase in systems complexity, mainly when the presence of human beings and their interactions with the system introduces a dynamic variable not easily manageable during design phases. Design and implementation of this type of systems highlight the problem of making the system able to decide in autonomy. In this work we propose an implementation, based on Jason, of a cognitive architecture whose modules allow structuring the decision-making process by the internal states of the agents, thus combining aspects of self-modeling and theory of the min

Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine.

OBJECTIVE: Circulatory shock is a life-threatening syndrome resulting in multiorgan failure and a high mortality rate. The aim of this consensus is to provide support to the bedside clinician regarding the diagnosis, management and monitoring of shock. METHODS: The European Society of Intensive Care Medicine invited 12 experts to form a Task Force to update a previous consensus (Antonelli et al.: Intensive Care Med 33:575-590, 2007). The same five questions addressed in the earlier consensus were used as the outline for the literature search and review, with the aim of the Task Force to produce statements based on the available literature and evidence. These questions were: (1) What are the epidemiologic and pathophysiologic features of shock in the intensive care unit ? (2) Should we monitor preload and fluid responsiveness in shock ? (3) How and when should we monitor stroke volume or cardiac output in shock ? (4) What markers of the regional and microcirculation can be monitored, and how can cellular function be assessed in shock ? (5) What is the evidence for using hemodynamic monitoring to direct therapy in shock ? Four types of statements were used: definition, recommendation, best practice and statement of fact. RESULTS: Forty-four statements were made. The main new statements include: (1) statements on individualizing blood pressure targets; (2) statements on the assessment and prediction of fluid responsiveness; (3) statements on the use of echocardiography and hemodynamic monitoring. CONCLUSIONS: This consensus provides 44 statements that can be used at the bedside to diagnose, treat and monitor patients with shock

Fitting the integrated Spectral Energy Distributions of Galaxies

Fitting the spectral energy distributions (SEDs) of galaxies is an almost universally used technique that has matured significantly in the last decade. Model predictions and fitting procedures have improved significantly over this time, attempting to keep up with the vastly increased volume and quality of available data. We review here the field of SED fitting, describing the modelling of ultraviolet to infrared galaxy SEDs, the creation of multiwavelength data sets, and the methods used to fit model SEDs to observed galaxy data sets. We touch upon the achievements and challenges in the major ingredients of SED fitting, with a special emphasis on describing the interplay between the quality of the available data, the quality of the available models, and the best fitting technique to use in order to obtain a realistic measurement as well as realistic uncertainties. We conclude that SED fitting can be used effectively to derive a range of physical properties of galaxies, such as redshift, stellar masses, star formation rates, dust masses, and metallicities, with care taken not to over-interpret the available data. Yet there still exist many issues such as estimating the age of the oldest stars in a galaxy, finer details ofdust properties and dust-star geometry, and the influences of poorly understood, luminous stellar types and phases. The challenge for the coming years will be to improve both the models and the observational data sets to resolve these uncertainties. The present review will be made available on an interactive, moderated web page (sedfitting.org), where the community can access and change the text. The intention is to expand the text and keep it up to date over the coming years.Comment: 54 pages, 26 figures, Accepted for publication in Astrophysics & Space Scienc

Ultraviolet and Infrared Diagnostics of Star Formation and Dust in NGC 7331

We present images of NGC 7331 obtained with GALEX and Spitzer, tracing UV and IR signatures of star formation. NGC 7331's morphology at 8-850 μm is dominated by a central dust ring. This structure is a vigorous site of star formation (hosting one-third of the present activity) but remains inconspicuous in our GALEX UV imagery. Radial profile analysis and photometry for discrete UV- and UV+IR-selected substructures indicate a decline in UV extinction with increasing galactocentric distance, although highly attenuated star-forming regions can be found throughout the disk. UV-optical surface brightness profiles suggest a recent birthrate parameter (b_8) that is highest in the outer part of the disk, even though the local star formation intensity peaks in the ring. Bolometric luminosity and UV attenuation are correlated in substructures on 0.4 kpc scales, with a relationship similar to that established for starburst galaxies. The distribution of substructures in L(IR)/L(FUV), L_λ(FUV)/L_λ(NUV) space suggests that the majority of the disk is best characterized by Milky Way-type dust, with the exception of sources in the star-forming ring. As found by Calzetti et al. in M51, the observed 8 and 24 μm luminosity for substructures in NGC 7331 are correlated, showing a decline in L_ν(8 μm)/L_ν(24 μm) with increasing luminosity. We demonstrate the dependence of L_ν(8 μm)/L_ν(24 μm) on the local extinction-corrected Hα surface brightness (hence current Σ_(SFR)). A power law of slope 1.64 (1.87) accurately describes the Schmidt-law relation versus Σ_(H_2) (Σ_(gas)) for molecular-dominated environments. The same locations show no correlation between Σ_(SFR) and Σ_(HI). For atomic-dominated regions above an apparent local star formation threshold, we found a trend for increasing Σ_(SFR) at higher Σ_(HI) , although the Schmidt-law correlation with molecular-only surface density persists in areas dominated by atomic gas

Phosphorylation of Rab-coupling protein by LMTK3 controls Rab14-dependent EphA2 trafficking to promote cell:cell repulsion

The Rab GTPase effector, Rab-coupling protein (RCP) is known to promote invasive behaviour in vitro by controlling integrin and receptor tyrosine kinase (RTK) trafficking, but how RCP influences metastasis in vivo is unclear. Here we identify an RTK of the Eph family, EphA2, to be a cargo of an RCP-regulated endocytic pathway which controls cell:cell repulsion and metastasis in vivo. Phosphorylation of RCP at Ser435 by Lemur tyrosine kinase-3 (LMTK3) and of EphA2 at Ser897 by Akt are both necessary to promote Rab14-dependent (and Rab11-independent) trafficking of EphA2 which generates cell:cell repulsion events that drive tumour cells apart. Genetic disruption of RCP or EphA2 opposes cell:cell repulsion and metastasis in an autochthonous mouse model of pancreatic adenocarcinoma—whereas conditional knockout of another RCP cargo, α5 integrin, does not suppress pancreatic cancer metastasis—indicating a role for RCP-dependent trafficking of an Eph receptor to drive tumour dissemination in vivo

Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells

BACKGROUND: Nitrogen-containing bisphosphonates (N-BPs) have been designed to inhibit osteoclast-mediated bone resorption. However, it is now accepted that part of their anti-tumor activities is related to interference with the mevalonate pathway. METHODS: We investigated the effects of zoledronic acid (ZOL), on cell proliferation and protein isoprenylation in two tumoral (LnCAP, PC-3,), and one normal established (PNT1-A) prostatic cell line. To assess if inhibition of geranyl-geranylation by ZOL impairs the biological activity of RhoA GTPase, we studied the LPA-induced formation of stress fibers. The inhibitory effect of ZOL on geranyl geranyl transferase I was checked biochemically. Activity of ZOL on cholesterol biosynthesis was determined by measuring the incorporation of (14)C mevalonate in cholesterol. RESULTS: ZOL induced dose-dependent inhibition of proliferation of all the three cell lines although it appeared more efficient on the untransformed PNT1A. Whatever the cell line, 20 μM ZOL-induced inhibition was reversed by geranyl-geraniol (GGOH) but neither by farnesol nor mevalonate. After 48 hours treatment of cells with 20 μM ZOL, geranyl-geranylation of Rap1A was abolished whereas farnesylation of HDJ-2 was unaffected. Inhibition of Rap1A geranyl-geranylation by ZOL was rescued by GGOH and not by FOH. Indeed, as observed with treatment by a geranyl-geranyl transferase inhibitor, treatment of PNT1-A cells with 20 μM ZOL prevented the LPA-induced formation of stress fibers. We checked that in vitro ZOL did not inhibit geranyl-geranyl-transferase I. ZOL strongly inhibited cholesterol biosynthesis up to 24 hours but at 48 hours 90% of this biosynthesis was rescued. CONCLUSION: Although zoledronic acid is currently the most efficient bisphosphonate in metastatic prostate cancer management, its mechanism of action in prostatic cells remains unclear. We suggest in this work that although in first intention ZOL inhibits FPPsynthase its main biological actitivity is directed against protein Geranylgeranylation